Association of common genetic variants in SMAD7 and risk of colon cancer
AUTOR(ES)
Thompson, Cheryl L.
FONTE
Oxford University Press
RESUMO
Two recent genome-wide association studies (GWAS) identified three common variants in SMAD7 (rs4464148, rs4939827 and rs12953717) that confer modest susceptibility to colorectal cancer. Here, we replicated the association of rs4464148 with colon cancer in a population-based case–control study (561 cases and 721 controls). Compared with the TT genotype, those with CT and CC had an adjusted odds ratio (OR) and 95% confidence interval of 1.06 (0.82–1.38) and 1.86 (1.17–2.96), respectively (Ptrend = 0.04). However, stratified analyses revealed that this association was limited to women only [OR = 1.25 (0.88–1.78) for CT and OR = 2.76 (1.53–4.98) for CC, Ptrend = 0.002, Pinteraction = 0.08], which was not noted in any GWAS. Similarly, we found evidence for association with both rs4939827 and rs12953717 in women only (P = 0.007 in dominant rs4939827 model and P = 0.015 in recessive rs12953717 model), but not in men (P > 0.05) and evidence of an interaction with gender (P = 0.015 for rs4939827 and P = 0.061 for rs12953717). Similar effect modification was found in haplotype analyses. Our data add evidence supporting these genetic variants as markers predisposing to colon cancer, specifically in women.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2691142Documentos Relacionados
- Personalized Gene Expression Analyses of SMAD7 and KLF10 In Breast Cancer
- Apoptosis in podocytes induced by TGF-β and Smad7
- Deficient Smad7 expression: A putative molecular defect in scleroderma
- Transforming growth factor β-inducible independent binding of SMAD to the Smad7 promoter
- GATA- and Smad1-Dependent Enhancers in the Smad7 Gene Differentially Interpret Bone Morphogenetic Protein Concentrations